The Cost-Effectiveness of Depression Treatment for Co-Occurring Disorders

A Clinical Trial

Published In: Journal of Substance Abuse Treatment, v. 46, no. 2, Feb. 2014, p. 128-133

Posted on on January 01, 2013

by Katherine E. Watkins, Alison Evans Cuellar, Kimberly A. Hepner, Sarah B. Hunter, Susan M. Paddock, Brett Ewing, Erin Dela Cruz

Read More

Access further information on this document at Elsevier Inc

This article was published outside of RAND. The full text of the article can be found at the link above.

Research Question

  1. Is it cost-effective to provide on-site group cognitive behavioral therapy for depression to clients receiving residential treatment for substance abuse?

The authors aimed to determine the economic value of providing on-site group cognitive behavioral therapy (CBT) for depression to clients receiving residential substance use disorder (SUD) treatment. Using a quasi-experimental design and an intention-to-treat analysis, the incremental cost-effectiveness and cost-utility ratio of the intervention were estimated relative to usual care residential treatment. The average cost of a treatment episode was $908, compared to $180 for usual care. The incremental cost effectiveness ratio was $131 for each point improvement of the BDI-II and $49 for each additional depression-free day. The incremental cost–utility ratio ranged from $9,249 to $17,834 for each additional quality adjusted life year. Although the intervention costs substantially more than usual care, the cost effectiveness and cost–utility ratios compare favorably to other depression interventions. Health care reform should promote dissemination of group CBT to individuals with depression in residential SUD treatment.

Key Findings

  • Providing on-site group cognitive behavior therapy (CBT) on site costs more than usual care for those receiving residential treatment for substance abuse.
  • However, the cost-effectiveness and cost-utility ratios of on-site CBT compare favorably to other depression interventions.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.